Dr. Li Deng of Helmholtz Zentrum München has been awarded a Starting Grant of the European Research Council (ERC). The scientist intends to tackle antimicrobial resistance by fighting bacteria with their natural enemies – the viruses. The grant is endowed with nearly 1.5 million euros for five years.
Emergence of antimicrobial resistance is a major threat to global health. Worldwide, more than 700,000 people died due to impaired action of antibiotic agents, and it is estimated to cause 10 million deaths a year by 2050.
Li Deng, head of an Emmy-Noether Young Investigator Group at the Institute of Virology of Helmholtz Zentrum München and junior fellow at the Technical University of Munich, aims to tackle this problem with a new approach. In the framework of the newly founded ERC project PHARMS (Bacteriophage inhibition of antibiotic-resistant pathogenic microbes and founding of novel therapeutic strategies), she plans to fight pathogenic bacteria with their natural enemies – the viruses.
To this end, she uses viruses which specifically attack bacteria, so called bacteriophages. “With our approach we use the viruses and phage-derived inhibitors as a natural way to fight antimicrobial resistance”, Li Deng explains.
“We hope that this might become a promising complement to antibiotics.” According to the scientist, the main obstacles in the clinical application of phage-based therapy are the limited number of phage isolates and the unknown molecular mechanisms of phage-delivered bactericidal action. “Moreover, we know too little about the mechanisms behind these bactericidal effects.”
Building on the recent advances of Deng’s group, PHARMS aims to deploy a systematic approach to identify the underlying mechanisms for phage inhibition of resistant bacteria strains. Based on this, the scientists aim to develop further phage derived therapeutic strategies.
Using an interdisciplinary research plan, PHARMS will discover phage-specific bactericidal action modes at all possible levels ranging from nucleotide sequence and transcription to translation, in order to elucidate the molecular mechanisms driving phage-mediated inhibition of antimicrobial resistance. One example of the respective bacteria is Helicobacter pylori which is often found in the stomach and linked to gastric ulcers and stomach cancer.
In the long run, the project is positioned to provide the rational framework for the design of novel therapeutic strategies aimed at treating common and life-threatening infectious diseases. “The rapid spread of antimicrobial resistance, and its devastating consequences for patients as well as healthy individuals, makes it one of the most important scientific challenges of our time”, Li Deng says. “Our work aims at making helpful contributions to society in this context.”
The Helmholtz Zentrum München, the German Research Center for Environmental Health, pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München is headquartered in Neuherberg in the north of Munich and has about 2,300 staff members. It is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 37,000 staff members. http://www.helmholtz-muenchen.de/en
The Institute of Virology (VIRO) investigates viruses that chronically infect humans and can cause life-threatening diseases. The research activities of the institute focus mainly on the HI virus which causes AIDS, on endogenous retroviruses, which are integrated into our germline, and hepatitis B and C viruses, which cause liver cirrhosis and hepatocellular carcinoma. Molecular studies identify new diagnostic and therapeutic concepts to prevent and treat these viral diseases or to prevent the formation of virus-induced tumors. http://www.helmholtz-muenchen.de/viro
Contact for the media:
Department of Communication, Helmholtz Zentrum München – German Research Center for Environmental Health (GmbH), Ingolstädter Landstr. 1, 85764 Neuherberg – Tel. +49 89 3187-2238 – E-mail: firstname.lastname@example.org
Dr. Li Deng, Helmholtz Zentrum München - German Research Center for Environmental Health, Institute of Virology, Ingolstädter Landstr. 1, 85764 Neuherberg – Tel. +49 89 3187-49195 – E-mail: email@example.com
http://Please find a CV of Li Deng (https://www.helmholtz-muenchen.de/viro/institute/about-us/staff/staff/ma/6317/Dr...) as well as more information about research of her lab in the Institute of Virology on the Helmholtz Zentrum München website: https://www.helmholtz-muenchen.de/viro/research/emmy-noether-research-group-vira...
Sonja Opitz | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Blocking the iron transport could stop tuberculosis
02.04.2020 | University of Zurich
Discovery of life in solid rock deep beneath sea may inspire new search for life on Mars
02.04.2020 | University of Tokyo
90 million-year-old forest soil provides unexpected evidence for exceptionally warm climate near the South Pole in the Cretaceous
An international team of researchers led by geoscientists from the Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research (AWI) have now...
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply. When the iron transport into the bacteria is inhibited, the pathogen can no longer grow. This opens novel ways to develop targeted tuberculosis drugs.
One of the most devastating pathogens that lives inside human cells is Mycobacterium tuberculosis, the bacillus that causes tuberculosis. According to the...
An international team with the participation of Prof. Dr. Michael Kues from the Cluster of Excellence PhoenixD at Leibniz University Hannover has developed a new method for generating quantum-entangled photons in a spectral range of light that was previously inaccessible. The discovery can make the encryption of satellite-based communications much more secure in the future.
A 15-member research team from the UK, Germany and Japan has developed a new method for generating and detecting quantum-entangled photons at a wavelength of...
Together with their colleagues from the University of Würzburg, physicists from the group of Professor Alexander Szameit at the University of Rostock have devised a “funnel” for photons. Their discovery was recently published in the renowned journal Science and holds great promise for novel ultra-sensitive detectors as well as innovative applications in telecommunications and information processing.
The quantum-optical properties of light and its interaction with matter has fascinated the Rostock professor Alexander Szameit since College.
Researchers at the University of Zurich show that different stem cell populations are innervated in distinct ways. Innervation may therefore be crucial for proper tissue regeneration. They also demonstrate that cancer stem cells likewise establish contacts with nerves. Targeting tumour innervation could thus lead to new cancer therapies.
Stem cells can generate a variety of specific tissues and are increasingly used for clinical applications such as the replacement of bone or cartilage....
02.04.2020 | Event News
26.03.2020 | Event News
23.03.2020 | Event News
02.04.2020 | Physics and Astronomy
02.04.2020 | Information Technology
02.04.2020 | Health and Medicine